Shanghai Shen Lian Biomedical Corporation (SHA:688098)
China · Delayed Price · Currency is CNY 9.97
+0.01 (0.10%)
Jan 23, 2026, 3:00 PM CST
SHA:688098 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -30.34 | -44.74 | 31.52 | 61.1 | 110.2 | 129.51 | Upgrade |
Depreciation & Amortization | 68.36 | 68.36 | 63.45 | 57.07 | 43.74 | 20.75 | Upgrade |
Other Amortization | 0.28 | 0.28 | - | - | - | 0.04 | Upgrade |
Loss (Gain) From Sale of Assets | -0.04 | -0.04 | -0 | -0.14 | 0.6 | 0.05 | Upgrade |
Asset Writedown & Restructuring Costs | 28.46 | 28.46 | 0.4 | 0.24 | - | - | Upgrade |
Loss (Gain) From Sale of Investments | -2.67 | -2.67 | -5.79 | -3.31 | -12.08 | -15.32 | Upgrade |
Provision & Write-off of Bad Debts | 8.45 | 8.45 | 3.12 | 8.5 | 1.65 | -0.48 | Upgrade |
Other Operating Activities | -48.91 | -3.93 | -1.68 | -0.11 | -5.82 | -0.16 | Upgrade |
Change in Accounts Receivable | 5.03 | 5.03 | -52.18 | -78.96 | -27.68 | -29.76 | Upgrade |
Change in Inventory | 16.68 | 16.68 | 3.58 | -11.9 | -32.27 | -15.52 | Upgrade |
Change in Accounts Payable | 21.42 | 21.42 | -33.15 | -17.88 | 5.25 | 8.56 | Upgrade |
Change in Other Net Operating Assets | - | - | -6.81 | -6.14 | 5.07 | 18.38 | Upgrade |
Operating Cash Flow | 58.78 | 89.36 | 3.53 | 9.09 | 90.12 | 111.73 | Upgrade |
Operating Cash Flow Growth | -16.83% | 2434.71% | -61.21% | -89.92% | -19.34% | 107.63% | Upgrade |
Capital Expenditures | -74.06 | -84.91 | -129.63 | -93.12 | -188.16 | -163.56 | Upgrade |
Sale of Property, Plant & Equipment | 0.52 | - | - | 0.86 | 0.5 | 0 | Upgrade |
Investment in Securities | -3.5 | 78.94 | 141.45 | 119.3 | 49.4 | 57.6 | Upgrade |
Other Investing Activities | 1.35 | 2.29 | 10.05 | 8.98 | 11.06 | 15.86 | Upgrade |
Investing Cash Flow | -75.7 | -3.68 | 21.86 | 36.01 | -127.21 | -90.1 | Upgrade |
Long-Term Debt Issued | - | 14 | - | - | - | - | Upgrade |
Total Debt Issued | 14 | 14 | - | - | - | - | Upgrade |
Long-Term Debt Repaid | - | -0.78 | -0.37 | -0.12 | -0.14 | -30 | Upgrade |
Net Debt Issued (Repaid) | 12.66 | 13.22 | -0.37 | -0.12 | -0.14 | -30 | Upgrade |
Issuance of Common Stock | - | - | - | - | 8.14 | - | Upgrade |
Common Dividends Paid | -0.21 | -14.35 | -32.77 | -36.81 | -40.81 | -33.86 | Upgrade |
Other Financing Activities | -19.62 | -18.23 | 0.05 | 0.24 | 0.51 | -0 | Upgrade |
Financing Cash Flow | -7.17 | -19.36 | -33.09 | -36.7 | -32.3 | -63.86 | Upgrade |
Foreign Exchange Rate Adjustments | 0 | 0 | 0 | 0 | -0 | -0 | Upgrade |
Net Cash Flow | -24.09 | 66.33 | -7.71 | 8.4 | -69.39 | -42.23 | Upgrade |
Free Cash Flow | -15.28 | 4.45 | -126.11 | -84.04 | -98.04 | -51.83 | Upgrade |
Free Cash Flow Margin | -5.22% | 1.47% | -41.83% | -25.57% | -27.35% | -15.35% | Upgrade |
Free Cash Flow Per Share | -0.04 | 0.01 | -0.32 | -0.21 | -0.24 | -0.12 | Upgrade |
Cash Income Tax Paid | 13.66 | 15.06 | 30.93 | 24.25 | 28.43 | 37.03 | Upgrade |
Levered Free Cash Flow | 6.6 | 18.35 | -113.08 | -92.62 | -126.34 | -121.62 | Upgrade |
Unlevered Free Cash Flow | 6.74 | 18.36 | -113.08 | -92.62 | -126.34 | -121.62 | Upgrade |
Change in Working Capital | 35.19 | 35.19 | -87.5 | -114.26 | -48.17 | -22.65 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.